[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Avitzur et al., 2014 - Google Patents

Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease

Avitzur et al., 2014

View PDF
Document ID
17573099938767176934
Author
Avitzur Y
Guo C
Mastropaolo L
Bahrami E
Chen H
Zhao Z
Elkadri A
Dhillon S
Murchie R
Fattouh R
Huynh H
Walker J
Wales P
Cutz E
Kakuta Y
Dudley J
Kammermeier J
Powrie F
Shah N
Walz C
Nathrath M
Kotlarz D
Puchaka J
Krieger J
Racek T
Kirchner T
Walters T
Brumell J
Griffiths A
Rezaei N
Rashtian P
Najafi M
Monajemzadeh M
Pelsue S
McGovern D
Uhlig H
Schadt E
Klein C
Snapper S
Muise A
Publication year
Publication venue
Gastroenterology

External Links

Snippet

Background & Aims Very early onset inflammatory bowel diseases (VEOIBD), including infant disorders, are a diverse group of diseases found in children younger than 6 years of age. They have been associated with several gene variants. Our aim was to identify the …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Avitzur et al. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease
Zhang et al. A DNAH17 missense variant causes flagella destabilization and asthenozoospermia
Morgantini et al. Liver macrophages regulate systemic metabolism through non-inflammatory factors
Burstein et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions
Huang et al. A robust TDP-43 knock-in mouse model of ALS
Xu et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells
Ugolino et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling
Smith et al. Associations among genotype, clinical phenotype, and intracellular localization of trafficking proteins in ARC syndrome
Castroflorio et al. The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour
Lane et al. Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-β peptide
Wu et al. The antioxidant protein Oxr1 influences aspects of mitochondrial morphology
Yehezkely et al. Intracellular role for the matrix-modifying enzyme lox in regulating transcription factor subcellular localization and activity in muscle regeneration
Xu et al. Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis
Xiong et al. Retromer in osteoblasts interacts with protein phosphatase 1 regulator subunit 14C, terminates parathyroid hormone's signaling, and promotes its catabolic response
You et al. Selenoprotein K contributes to CD36 subcellular trafficking in hepatocytes by accelerating nascent COPII vesicle formation and aggravates hepatic steatosis
Gan et al. Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone
Li et al. Succinate dehydrogenase is essential for epigenetic and metabolic homeostasis in hearts
Kapp et al. C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinib
Yang et al. Hepatic DKK1-driven steatosis is CD36 dependent
Silvaroli et al. Genome-wide CRISPR screen identifies phospholipid scramblase 3 as the biological target of mitoprotective drug SS-31
Shu et al. A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family
He et al. Cardiac CIP protein regulates dystrophic cardiomyopathy
Meng et al. Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner
Tunon et al. Danon disease: a novel Lamp-2 gene mutation in a family with four affected members
Bertino et al. Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus